Significant Risk of Life Threatening Infections in Elderly Patients With Inflammatory Bowel Disease Receiving Anti-TNF Therapy

被引:0
|
作者
Azmi, Ahmad Najib
Lee, Way-Seah
Ng, Ruey Terng
Ong, Sik-Yong
Mahadeva, Sanjiv
Goh, Khean-Lee
Hilmi, Ida
机构
关键词
D O I
10.1016/j.cgh.2015.04.042
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1385 / 1386
页数:3
相关论文
共 50 条
  • [1] INFLAMMATORY BOWEL DISEASE: THE CONSEQUENCES OF ANTI-TNF THERAPY IN THE ELDERLY
    Ali, M.
    McClean, C.
    Zou, Y.
    Goh, J.
    GUT, 2016, 65 : A256 - A257
  • [2] Efficacy and Safety of Anti-TNF Therapy in Elderly Patients With Inflammatory Bowel Disease
    Ortega, Triana Lobaton
    Vermeire, Severine
    Ballet, Vera
    Rutgeerts, Paul J.
    Van Assche, Gert A.
    Ferrante, Marc
    GASTROENTEROLOGY, 2014, 146 (05) : S579 - S579
  • [3] Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease
    Lobaton, T.
    Ferrante, M.
    Rutgeerts, P.
    Ballet, V.
    Van Assche, G.
    Vermeire, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (04) : 441 - 451
  • [4] Serial Tuberculosis Screening in Inflammatory Bowel Disease Patients Receiving Anti-TNFα Therapy
    Abreu, Candida
    Afonso, Joana
    Dias, Claudia Camila
    Ruas, Rogerio
    Sarmento, Antonio
    Magro, Fernando
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (10): : 1223 - 1229
  • [5] Anti-TNF alpha therapy in Inflammatory Bowel Disease - safety profile in elderly patients
    Bernardes, C.
    Carvalho, D.
    Russo, P.
    Saiote, J.
    Ramos, J.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S400 - S400
  • [6] Elderly patients with inflammatory bowel disease under anti-TNF therapy: efficacy and safety
    Ortega, T. Lobaton
    Vermeire, S.
    Ballet, V.
    Rutgeerts, P.
    Van Assche, G.
    Ferrante, M.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S273 - S273
  • [7] ADVERSE EVENTS IN ELDERLY INFLAMMATORY BOWEL DISEASE PATIENTS MANAGED WITH ANTI-TNF THERAPY
    Winters, Conchubhair
    Mooney, Peter
    GUT, 2018, 67 : A101 - A101
  • [8] Increased Discontinuation Rates of Anti-TNF Therapy in Elderly Inflammatory Bowel Disease Patients
    de Jong, M. E.
    Smits, L. J. T.
    van Ruijven, B.
    den Broeder, N.
    Russel, M. G. V. M.
    Romkens, T. E. H.
    West, R. L.
    Jansen, J. M.
    Hoentjen, F.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (07): : 888 - 895
  • [9] Optimization of anti-TNF therapy in patients with Inflammatory Bowel Disease
    Strik, A. S.
    Bots, S. J. A.
    D'Haens, G.
    Lowenberg, M.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (03) : 429 - 439
  • [10] Risk of Lymphoma Associated with Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: Implications for Therapy
    Dahmus, Jessica
    Rosario, Michelle
    Clarke, Kofi
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2020, 13 : 339 - 350